156 related articles for article (PubMed ID: 32995455)
1. Prevalence of endometrial cancer symptoms among overweight and obese women presenting to a multidisciplinary weight management center.
Beavis AL; Najjar O; Cheskin LJ; Mangal R; Rositch AF; Langham G; Fader AN
Gynecol Oncol Rep; 2020 Nov; 34():100643. PubMed ID: 32995455
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
[TBL] [Abstract][Full Text] [Related]
4. Rate of premalignant and malignant endometrial lesion in "low-risk" premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy.
Jha S; Singh A; Sinha HH; Bhadani P; Anant M; Agarwal M
Obstet Gynecol Sci; 2021 Nov; 64(6):517-523. PubMed ID: 34555870
[TBL] [Abstract][Full Text] [Related]
5. Identifying women 45 years and younger at elevated risk for endometrial hyperplasia or cancer.
Beavis AL; Blechter B; Najjar O; Fader AN; Katebi Kashi P; Rositch AF
Gynecol Oncol; 2023 Jul; 174():98-105. PubMed ID: 37172411
[TBL] [Abstract][Full Text] [Related]
6. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women.
Kim MJ; Kim JJ; Kim SM
Obstet Gynecol Sci; 2016 May; 59(3):192-200. PubMed ID: 27200309
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.
Henderson I; Black N; Khattak H; ; Gupta JK; Rimmer MP
PLoS Med; 2024 Feb; 21(2):e1004346. PubMed ID: 38421942
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments.
Zhao J; Hu Y; Zhao Y; Chen D; Fang T; Ding M
BMC Womens Health; 2021 Aug; 21(1):312. PubMed ID: 34433451
[TBL] [Abstract][Full Text] [Related]
9. Endometrial hyperplasia in pre-menopausal women: A systematic review of incidence, prevalence, and risk factors.
Petersdorf K; Groettrup-Wolfers E; Overton PM; Seitz C; Schulze-Rath R
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():158-171. PubMed ID: 35217456
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study.
Jeong JY; Hwang SO; Lee B; Kim K; Kim YB; Park SH; Choi HY
PLoS One; 2020; 15(12):e0243064. PubMed ID: 33259545
[TBL] [Abstract][Full Text] [Related]
11. The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study.
Yuk JS
PeerJ; 2016; 4():e2374. PubMed ID: 27635340
[TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer patients understanding and interest in weight loss surgery.
Wiley RL; Urbauer DL; Nugent E; Gallegos J; Ramondetta L
Gynecol Oncol; 2023 Aug; 175():88-92. PubMed ID: 37329873
[TBL] [Abstract][Full Text] [Related]
13. Endometrial Cancer Associated Symptoms: A Case-Control Study.
Pakish JB; Lu KH; Sun CC; Burzawa JK; Greisinger A; Smith FA; Fellman B; Urbauer DL; Soliman PT
J Womens Health (Larchmt); 2016 Nov; 25(11):1187-1192. PubMed ID: 27254529
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical data of different endometrial pathological types in perimenopausal women with abnormal uterine bleeding.
Wang L; Quan S; Bai E; Yang X
Front Oncol; 2024; 14():1370681. PubMed ID: 38487719
[TBL] [Abstract][Full Text] [Related]
15. Association of endometrial hyperplasia and cancer with a history of gestational diabetes.
Wartko PD; Beck TL; Reed SD; Mueller BA; Hawes SE
Cancer Causes Control; 2017 Aug; 28(8):819-828. PubMed ID: 28577154
[TBL] [Abstract][Full Text] [Related]
16. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
17. Role of transvaginal ultrasonography in diagnosing endometrial hyperplasia in pre- and post-menopause women.
Shokouhi B
Niger Med J; 2015; 56(5):353-6. PubMed ID: 26778888
[TBL] [Abstract][Full Text] [Related]
18. Endometrial Cancer Risk Prediction According to Indication of Diagnostic Hysteroscopy in Post-Menopausal Women.
Saccardi C; Vitagliano A; Marchetti M; Lo Turco A; Tosatto S; Palumbo M; De Lorenzo LS; Vitale SG; Scioscia M; Noventa M
Diagnostics (Basel); 2020 Apr; 10(5):. PubMed ID: 32349386
[TBL] [Abstract][Full Text] [Related]
19. Knowledge of endometrial cancer risk factors in a general gynecologic population.
Washington CR; Haggerty A; Ronner W; Neff PM; Ko EM
Gynecol Oncol; 2020 Jul; 158(1):137-142. PubMed ID: 32402632
[TBL] [Abstract][Full Text] [Related]
20. Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women.
Kuai D; Tang Q; Tian W; Zhang H
Discov Oncol; 2023 Jul; 14(1):121. PubMed ID: 37395825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
